Old API Wind-down Ltd. Share Price

Stocks

ARLZQ

CA03852X1006

Pharmaceuticals

OTC Markets Traded
Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Old API Wind-down Ltd. -.--% -

Valuation: Old API Wind-down Ltd.

Market Cap 87.35T 76.62T 70.96T 65.29T 1L 83.61L 1L 8L 3L 41.06L 3L 3L 1.42Cr P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 25Cr 22Cr 20Cr 18Cr 35Cr 2.35TCr 35Cr 237.93Cr 93Cr 1.16TCr 92Cr 90Cr 3.99TCr EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.56%-1.52%+47.86%+171.88% 1,06000Cr
+0.31%-0.60%+64.37%+62.31% 62TCr
-0.03%-2.65%+29.49%+85.64% 44TCr
-1.75%-2.91%+28.78%+24.35% 33TCr
+0.24%-2.61%+29.46%+46.50% 28TCr
-1.75%-10.57%+18.27%+22.07% 27TCr
+0.67%+1.03%-26.81%-37.96% 22TCr
-0.81%-1.63%+21.35%+58.33% 20TCr
+1.21%+1.38%+17.23%+71.29% 16TCr
Average -0.34%-3.00%+25.55%+56.05% 35.74TCr
Weighted average by Cap. -0.27%-3.10%+35.63%+83.95%

Financials

2016 2017
Net sales 5.43Cr 4.76Cr 4.41Cr 4.06Cr 7.67Cr 519.43Cr 7.82Cr 53Cr 21Cr 255.08Cr 20Cr 20Cr 880.92Cr 11Cr 9.29Cr 8.61Cr 7.92Cr 15Cr 1.01TCr 15Cr 102.58Cr 40Cr 497.97Cr 40Cr 39Cr 1.72TCr
Net income -10Cr -9.03Cr -8.37Cr -7.7Cr -15Cr -985.63Cr -15Cr -100Cr -39Cr -484.02Cr -39Cr -38Cr -1.67TCr -13Cr -11Cr -10Cr -9.36Cr -18Cr -1.2TCr -18Cr -121.23Cr -48Cr -588.49Cr -47Cr -46Cr -2.03TCr
Net Debt 21Cr 18Cr 17Cr 16Cr 30Cr 2.01TCr 30Cr 202.84Cr 80Cr 984.69Cr 79Cr 77Cr 3.4TCr 25Cr 22Cr 20Cr 18Cr 35Cr 2.35TCr 35Cr 237.85Cr 93Cr 1.15TCr 92Cr 90Cr 3.99TCr
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock